If you're in the market for high-quality hot glue sticks, look no further than Adtech W229-34ZIP100 Mini Hot Glue Sticks ...

Firearms were the leading cause of death for children and teenagers in the United States for the third consecutive year, and homicides accounted for the majority of gun deaths among the age group ...

Merck stock (NYSE: MRK) has gained over 65% in value since early January 2021 – jumping from levels of $70 then to around $115 now – vs. an increase of about 50% for the S&P 500 over this ...

Jefferies analyst Akash Tewari maintained a Buy rating on Merck & Company (MRK – Research Report) today and set a price target of $147.00. The company’s shares closed last Friday at $117.84.

A city councillor has withdrawn his call for an auditor-general probe of communication between the mayor and a non-profit executive over a Stoney Creek municipal parking lot eyed for affordable ...

For many parents, watching a group of boys mimic battles with sticks as guns or swords spells trouble. Odds are that they will tell the children to “stop before somebody gets hurt!” ...

Merck's business is growing, but the stock's gains have been modest this year. The drug manufacturer remains heavily reliant on Keytruda, which accounts for nearly half of its revenue. Merck has ...

Addition of CN201, a next generation CD3xCD19 bispecific antibody with potential applications in B-cell malignancies and autoimmune diseases, broadens and fortifies Merck’s pipeline RAHWAY ...

Kamala Harris hit back at Donald Trump during their debate on Thursday night by reminding him that she is a gun owner. After Trump accused the vice president of having a “plan to confiscate ...

Merck & Co.’s long-running effort to land a punch on small cell lung cancer (SCLC) has racked up a small victory. The drugmaker’s Daiichi Sankyo-partnered antibody-drug conjugate (ADC ...

The state does not have universal background checks for gun purchases, safe storage laws or a so-called red-flag law — measures instituted elsewhere in response to gun violence. By Emily ...

But that doesn’t necessarily threaten the market dominance of Keytruda, a top Merck executive said — and some analysts agree. “I see these results as important, but preliminary,” Merck ...